Comparative effcomparative effectiveness and safety of factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and malignant diseases, insights from the RELOADED study
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Schleswig-Holstein University Clinic, Lubeck Campus, Luebeck (Germany)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
You may be interested in
Congress Session
Congress Session
